Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lai Nar Tung"'
Publikováno v:
Journal of Biomedical Science, Vol 25, Iss 1, Pp 1-8 (2018)
Abstract Esophageal squamous cell carcinoma (ESCC) is the predominant subtype of esophageal cancer worldwide and highly prevalent in less developed regions. Management of ESCC is challenging and involves multimodal treatments. Patient prognosis is ge
Externí odkaz:
https://doaj.org/article/894487a5efb3469b93a66fb5525e086a
Autor:
Senchuan Song, Chung Man Chan, Hector K. Wang, Yanmin Huang, Lai Nar Tung, Ho Yu Lam, Hoi Ting Leung, Huacan Song, Zhiyong Chen, Mei Yuk Choi, Nikki P. Lee, Kin Tak Chan, Simon Law
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Tumor xenograft model is an indispensable animal cancer model. In esophageal squamous cell carcinoma (ESCC) research, orthotopic tumor xenograft model establishes tumor xenograft in the animal esophagus, which allows the study of tumorigenesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad8d02eb58b1aaab27c5878dce4a78fd
https://doi.org/10.4143/crt.2017.353
https://doi.org/10.4143/crt.2017.353
Autor:
Hector K. Wang, Edgar S. L. Liu, Zhaoxiang Bian, Lai Nar Tung, Ho Yu Lam, Mung Yee Wong, Winnie Tan, Kin Tak Chan, Nikki P. Lee, Mei Yuk Choi, Sarwat Fatima, Pui Ying Tam
Publikováno v:
Journal of Applied Life Sciences International. 4:1-10
Aims: Monoclonal antibodies against tumor-related molecules are therapeutic agents for cancers. Promising results support the use of monoclonal antibodies in several cancers such as lung and breast cancer. However, using monoclonal antibodies as ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dd4c1997ca4c707bed400a0c3a40277
https://doi.org/10.9734/jalsi/2016/22188
https://doi.org/10.9734/jalsi/2016/22188
Autor:
Nikki P. Lee, Daniel K. H. Tong, Mei Yuk Choi, Kin Tak Chan, Kenneth K. Y. Lai, Lai Nar Tung, Ho Yu Lam, Winnie Tan, Simon Law
Publikováno v:
Oncology Reports. 31:1296-1304
Esophageal squamous cell carcinoma (ESCC) is the predominant type of esophageal cancer in endemic Asian regions. In the present study, we investigated the clinical implication and role of transferrin receptor CD71 in ESCC. CD71 has a physiological ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::240bc091043e4e665b600174397c3344
https://doi.org/10.3892/or.2014.2981
https://doi.org/10.3892/or.2014.2981
Autor:
Lai Nar Tung, Kin Tak Chan, Ho Yu Lam, Fei Chuen Tzang, Sze Hang Lau, Sui Yi Kwok, Ian P. Y. Lam, Cornelia Man, Simon Law, Heron Han, Daniel K. Tong, Nikki P. Lee, Mei Yuk Choi, Bing L. Wong
Publikováno v:
Cancer chemotherapy and pharmacology. 76(6)
Adjunct chemoradiation is offered to unresectable esophageal squamous cell carcinoma (ESCC) patients, while its use is limited in tumors with strong resistance. Oxygen carriers or anti-hypoxic drugs belong to an emerging class of regulators that can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24b83a5df73a90dbbce73ff8770672b8
https://pubmed.ncbi.nlm.nih.gov/26553104
https://pubmed.ncbi.nlm.nih.gov/26553104
Autor:
Lai Nar Tung, Daniel K. H. Tong, Ho Yu Lam, Nikki P. Lee, Hector K. Wang, Raymond Wai-Yin Sun, Winnie Tan, Eva Yi Man Fung, Simon Law, Kenneth K. Y. Lai, Kin Tak Chan, Mei Yuk Choi
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 37(2)
Esophageal squamous cell carcinoma (ESCC) is the predominant type of esophageal cancer in Asia. Cisplatin is commonly used in chemoradiation for unresectable ESCC patients. However, the treatment efficacy is diminished in patients with established ci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5ad31993a800e74444c4d51dbb3479a
https://pubmed.ncbi.nlm.nih.gov/26346170
https://pubmed.ncbi.nlm.nih.gov/26346170